ADMETRx Now
ADMETRx takes an active leadership role in its industry, and has a strong professional presence in the field of discovery and preclinical ADME research.
As frequent invited speakers to national and international meetings, the ADMETRx Co-Founders, Phil Burton and Jay Goodwin may be in your area in the near future. Below is a list of just a few of their upcoming engagements.
News & Events
- Client Visit to North Carolina
- March 2-3, 2010
- Details: Phil Burton will be visiting with clients in the Raleigh/Durham area on March 2 & 3. If you would be interested in meeting with Phil and learning more about ADMETRx please contact us at 269.353.5541 or by email at mwarren@admetrx.com
News Releases
- ADMETRx Now Newsletter
- Details: ADMETRx offers new services and introduces additional staff.
- Download PDF
- ADMETRx & Roche Collaborate on Multicriteria Decision-Making Application
- Details: ADMETRx and Roche both recognize how
comprehensive data integration may offer significant advantages to discovery groups in selecting candidates for advancement. - Download PDF
- ADMETRx Now Newsletter
- Details: The drug discovery and development research business is all about picking winners - selecting which candidates to move forward that have therapeutic potential. At ADMETRx, we take that selection process very seriously.
- Download PDF
- 2006 FDA Draft Guidance
- Details: It makes sense. Given the number of compounds that fail in clinical trials, it seems logical to conduct ADME testing much earlier in the drug development process.
- Download PDF
If you are interested in meeting individually with Dr. Burton, please contact us at 269-372-3272
The scientific staff at ADMETRx has published extensively. Dr. Burton has recently published a timely paper entitled “The challenge of improving the drug discovery process - An early ADME perspective.” To receive a copy of this paper as well as a complete list of publications, please contact us.